FDA approves Tandem insulin pump

T:slim includes color touch screen

SAN DIEGO — The Food and Drug Administration has approved a new insulin-delivery system for Type 1 diabetes made by Tandem Diabetes Care, the company said Wednesday.

Tandem announced the approval of the T:slim, a pump that the company said is the first to have a color touch screen and is the smallest insulin pump system available, in addition to being one of the first to be approved under the FDA's new Infusion Pump Improvement initiative.

"With the clearance of T:slim, Tandem Diabetes Care has an opportunity to set a new standard in insulin pump infusion therapy," Tandem president and CEO Kim Blickenstaff said. "In creating T:slim, we spoke with more than 4,000 healthcare professionals and people with diabetes, and the clear message we heard was, 'Make it cool and make it uncomplicated to use. Give us access to the most advanced features without the extra effort.'"

Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

Login or Register to post a comment.